Actionnariat et activité des initiés pour Anika Therapeutics, Inc. (ANIK): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $21.03 |
| Capitalisation | $281M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-04 | Fischetti Gary P | P-Purchase | 1,000 | $20K |
| 2026-08-03 | Fischetti Gary P | P-Purchase | 1,000 | $21K |
| 2026-06-18 | Fischetti Gary P | A-Award | 10,402 | |
| 2026-06-18 | HENNEMAN JOHN B III | A-Award | 10,402 | |
| 2026-06-18 | Richard Stephen | A-Award | 10,402 | |
| 2026-06-18 | Capper Joseph H | A-Award | 10,402 | |
| 2026-06-18 | CONLEY SHERYL L | A-Award | 10,402 | |
| 2026-06-03 | Griffin Stephen D. | M-Exempt | 12,840 | |
| 2026-06-03 | Griffin Stephen D. | F-InKind | 3,769 | $54K |
| 2026-06-03 | Griffin Stephen D. | M-Exempt | 12,840 |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $104.3M | $133.3M | $89.0M | $157.5M | $95.8M | $94.4M | $86.3M | $68.7M | $55.6M | $57.5M |
| Placements à Court Terme | $20.5M | $24.0M | $70.0M | $27.5M | $2.5M | 0 | 0 | 0 | 0 | 0 |
| Créances | $27.6M | $23.8M | $20.8M | $23.1M | $24.1M | $29.8M | $34.6M | $26.4M | $23.6M | $23.7M |
| Stocks | $16.0M | $22.0M | $21.3M | $22.0M | $46.2M | $36.0M | $39.8M | $24.4M | $23.8M | $18.8M |
| Actifs Courants | $170.4M | $206.3M | $202.9M | $234.3M | $177.4M | $168.5M | $169.5M | $163.3M | $113.7M | $103.4M |
| Immobilisations Corporelles | $52.3M | $56.2M | $54.1M | $73.6M | $73.2M | $68.6M | $79.0M | $65.0M | $64.7M | $66.3M |
| Goodwill | $7.2M | $8.2M | $7.9M | $7.7M | $8.4M | $7.8M | $7.3M | $7.6M | $7.1M | $8.1M |
| Actifs Incorporels | $10.2M | $10.6M | $9.2M | $7.6M | $91.2M | $82.4M | $74.6M | $2.6M | $2.5M | $1.6M |
| Actifs Totaux | $240.2M | $282.6M | $279.0M | $330.7M | $365.6M | $347.5M | $349.1M | $270.6M | $202.7M | $190.3M |
| Dettes Fournisseurs | $2.3M | $6.7M | $3.1M | $3.8M | $9.0M | $7.6M | $9.1M | $6.2M | $5.6M | $6.0M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $8.8M | $13.1M | $11.3M | $16.3M | $36.9M | $29.8M | $27.9M | $31.1M | $23.3M | $21.9M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $24.2M |
| Passifs Totaux | $17.5M | $19.1M | $15.4M | $42.3M | $93.2M | $60.5M | $63.6M | $58.4M | $48.8M | $46.8M |
| Réserves | $168.2M | $199.5M | $218.2M | $245.4M | $221.4M | $225.6M | $210.7M | $128.1M | $71.7M | $60.8M |
| Capitaux Propres | $222.8M | $263.5M | $263.6M | $288.4M | $272.4M | $287.1M | $285.6M | $212.3M | $154.0M | $143.5M |
| Dette Totale | 0 | 0 | 0 | $22.5M | $22.5M | $21.0M | $30.9M | $27.7M | $25.9M | $26.2M |
| Dette Nette | -$124.8M | -$157.3M | -$159.0M | -$162.4M | -$75.9M | -$73.4M | -$55.4M | -$41.0M | -$29.7M | -$31.2M |
| Fonds de Roulement | $161.6M | $193.3M | $191.7M | $218.0M | $140.5M | $138.7M | $141.6M | $132.2M | $90.3M | $81.5M |
Santé financière
| Dette / Capitaux propres | 0.17 |
| Ratio de liquidité | 4.48 |
Rentabilité
| Rentabilité des capitaux propres | -2.70% |
| Rentabilité du capital investi | -3.17% |
| Rentabilité des actifs | -2.06% |
| Marge brute | 62.16% |
| Marge opérationnelle | -4.24% |
| Marge nette | -3.14% |
Entreprises liées: ANIX · APYX · ARAY · AVR · LNSR · LUCD · MXCT
Explorer le secteur: Healthcare · Medical - Specialties
Plus de sections de ANIK: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions